NBGUX
Price
$31.85
Change
-$0.02 (-0.06%)
Updated
Sep 12 closing price
Net Assets
2.64B
VIGIX
Price
$242.76
Change
+$0.87 (+0.36%)
Updated
Sep 12 closing price
Net Assets
328.49B
Interact to see
Advertisement

NBGUX vs VIGIX

Header iconNBGUX vs VIGIX Comparison
Open Charts NBGUX vs VIGIXBanner chart's image
Neuberger Berman Large Cap Growth Adv
Price$31.85
Change-$0.02 (-0.06%)
VolumeN/A
Net Assets2.64B
Vanguard Growth Index Institutional
Price$242.76
Change+$0.87 (+0.36%)
VolumeN/A
Net Assets328.49B
NBGUX vs VIGIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NBGUX vs. VIGIX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBGUX is a StrongBuy and VIGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 328B vs. NBGUX (2.64B). VIGIX pays higher dividends than NBGUX: VIGIX (0.43) vs NBGUX (0.00). NBGUX was incepted earlier than VIGIX: NBGUX (29 years) vs VIGIX (27 years). NBGUX (1.44) is less costly to investors than VIGIX (0.04). NBGUX is a more actively managed with annual turnover of: 30.00 vs. VIGIX (11.00). NBGUX has a lower initial minimum investment than VIGIX: NBGUX (0) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 26.06 vs. NBGUX (12.94). VIGIX return over 5 years is better than : 112.05 vs. NBGUX (44.17).
NBGUXVIGIXNBGUX / VIGIX
Total Expense Ratio1.440.043,600%
Annual Report Gross Expense Ratio1.440.043,600%
Fund Existence29 years27 years-
Gain YTD12.58414.92784%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.64B328B1%
Annual Yield % from dividends0.000.43-
Returns for 1 year12.9426.0650%
Returns for 3 years48.6298.9449%
Returns for 5 years44.17112.0539%
Returns for 10 years76.09352.9522%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX41.490.21
+0.51%
Patient Opportunity C
GGRCX16.830.05
+0.30%
Goldman Sachs Strategic Growth C
GTECX48.790.03
+0.06%
Gateway C
AWSIX17.87-0.06
-0.33%
Invesco Global Core Equity R5
BGGSX31.23-0.23
-0.73%
Baillie Gifford US Equity Growth I